Egetis to present Emcitate clinical data for MCT8 deficiency in September 2026
Egetis Therapeutics AB (EGTX) said clinical data for Emcitate (tiratricol) in the treatment of MCT8 deficiency will be presented at the 47th Annual Meeting of the European…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.